Cargando…

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease

BACKGROUND & AIMS: Phospholipase D1 (PLD1), a phosphatidylcholine-hydrolysing enzyme, is involved in cellular lipid metabolism. However, its involvement in hepatocyte lipid metabolism and consequently non-alcoholic fatty liver disease (NAFLD) has not been explicitly explored. METHODS: NAFLD was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huan, Zhao, Yushang, Pan, Yuhualei, Yang, Aiting, Li, Changying, Wang, Song, Dong, Zhao, Li, Mengyi, Wang, Songlin, Zhang, Zhongtao, Zhu, Yanbing, Zhang, Dong, Sun, Guangyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149370/ https://www.ncbi.nlm.nih.gov/pubmed/37138676 http://dx.doi.org/10.1016/j.jhepr.2023.100726

Ejemplares similares

TCRαβ(+)NK1.1(-)CD4(-)CD8(-) double-negative T cells inhibit central and peripheral inflammation and ameliorate ischemic stroke in mice
por: Tian, Dan, et al.
Publicado: (2023)

The Critical and Diverse Roles of CD4(–)CD8(–) Double Negative T Cells in Nonalcoholic Fatty Liver Disease
por: Li, Changying, et al.
Publicado: (2022)

Inhibition of Perforin-Mediated Neurotoxicity Attenuates Neurological Deficits After Ischemic Stroke
por: Pan, Yuhualei, et al.
Publicado: (2021)

The p66shc-mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
por: Zhang, Jing, et al.
Publicado: (2020)

Erratum: The p66shc-Mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
por: Zhang, Jing, et al.
Publicado: (2020)

Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice
por: Takahara, Ikuko, et al.
Publicado: (2017)

Primary Broiler Hepatocytes for Establishment of a Steatosis Model
por: Zhang, Cai, et al.
Publicado: (2022)

GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients
por: Li, Yaqiong, et al.
Publicado: (2021)

Inhibitory Effect of Gardenoside on Free Fatty Acid-Induced Steatosis in HepG2 Hepatocytes
por: Liang, Huiqing, et al.
Publicado: (2015)

PDIA3 Knockdown Exacerbates Free Fatty Acid-Induced Hepatocyte Steatosis and Apoptosis
por: Zhang, Xue-qun, et al.
Publicado: (2015)

Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice
por: Takahara, Ikuko, et al.
Publicado: (2020)

Activation of AMP-activated protein kinase signaling pathway ameliorates steatosis in laying hen hepatocytes
por: Zhang, Kun, et al.
Publicado: (2020)

Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease
por: Ran, Li-Sha, et al.
Publicado: (2022)

The Effect and Mechanism of Tamoxifen-Induced Hepatocyte Steatosis in Vitro
por: Zhao, Fei, et al.
Publicado: (2014)

Docosahexaenoic Acid Ameliorates Fructose-Induced Hepatic Steatosis Involving ER Stress Response in Primary Mouse Hepatocytes
por: Zheng, Jinying, et al.
Publicado: (2016)

Study of Valproic Acid-Enhanced Hepatocyte Steatosis
por: Chang, Renin, et al.
Publicado: (2016)

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan
por: SAWANO, TAKEYUKI, et al.
Publicado: (2015)

Alterations in the hepatocyte epigenetic landscape in steatosis
por: Maji, Ranjan Kumar, et al.
Publicado: (2023)

Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes
por: Wang, Chenxi, et al.
Publicado: (2021)

Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis
por: Daugherty, Alan, et al.
Publicado: (2019)

Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat
por: Zhang, Hanlin, et al.
Publicado: (2021)

Knockdown of hepatocyte Perilipin-3 mitigates hepatic steatosis and steatohepatitis caused by hepatocyte CGI-58 deletion in mice
por: Bao, Xinyu, et al.
Publicado: (2022)

P-Hydroxyacetophenone Ameliorates Alcohol-Induced Steatosis and Oxidative Stress via the NF-κB Signaling Pathway in Zebrafish and Hepatocytes
por: Huang, Sha, et al.
Publicado: (2020)

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
por: Wang, Pi-Xiao, et al.
Publicado: (2016)

Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice
por: Yu, Yongxiang, et al.
Publicado: (2021)

Steatosis is a Lot More than Holes in Hepatocytes
por: Chakrabarti, Subrata
Publicado: (2009)

Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes
por: Trepiana, Jenifer, et al.
Publicado: (2020)

D-Mannose Regulates Hepatocyte Lipid Metabolism via PI3K/Akt/mTOR Signaling Pathway and Ameliorates Hepatic Steatosis in Alcoholic Liver Disease
por: Hu, Mengyao, et al.
Publicado: (2022)

Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice
por: Zhu, Wei, et al.
Publicado: (2014)

Modulation of Insulin Sensitivity of Hepatocytes by the Pharmacological Downregulation of Phospholipase D
por: Babenko, Nataliya A., et al.
Publicado: (2015)

CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis
por: Sun, Guangyong, et al.
Publicado: (2021)

Cimifugin Ameliorates Lipotoxicity-Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK- and SIRT1-Involved Pathways
por: Yang, Wenwen, et al.
Publicado: (2022)

Apple pomace and rosemary extract ameliorates hepatic steatosis in fructose-fed rats: Association with enhancing fatty acid oxidation and suppressing inflammation
por: Bai, Ruojun, et al.
Publicado: (2020)

Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice
por: Kong, Qin, et al.
Publicado: (2016)

Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease
por: Li, Shan, et al.
Publicado: (2018)

Activity of Pterostilbene Metabolites against Liver Steatosis in Cultured Hepatocytes
por: Trepiana, Jenifer, et al.
Publicado: (2020)

Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats
por: Pastor, Catherine M., et al.
Publicado: (2021)

Alterations in Cytoskeleton and Mitochondria in the Development and Reversal of Steatosis in Human Hepatocytes
por: Fan, Letao, et al.
Publicado: (2023)

Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
por: Zhao, Ruifang, et al.
Publicado: (2020)

Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression
por: Li, Lu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a9l4mm18fb1ga8dr0dpd5oj9fs